Pipamperone
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
1'-[4-(4-fluorophenyl)-4-oxobutyl]-1,4'-bipiperidine-4'-carboxamide | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Pregnancy cat. | ? |
Legal status | ? |
Routes | Oral |
Identifiers | |
CAS number | 1893-33-0 |
ATC code | N05AD05 |
PubChem | CID 4830 |
IUPHAR ligand | 92 |
ChemSpider | 4664 |
UNII | 5402501F0W |
KEGG | D02622 |
ChEMBL | CHEMBL440294 |
Chemical data | |
Formula | C21H30FN3O2 |
Mol. mass | 375.480 g/mol |
|
|
|
|
(what is this?) (verify) |
Pipamperone is an antipsychotic drug (a butyrophenone derivative) used in the treatment of schizophrenia. Pipamperone is known to the general public under the marketed brand name Dipiperon. It was discovered at Janssen Pharmaceutica in 1960.
References [edit]
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |